Please find some materials about pretomanid and the BPaL regimen here.
Downloadable Factsheets
Videos
Nix-TB Clinical Trial B-Roll Clips
Password: BPaL2019
Password: BPaL2019
Patient Stories & Partner Quotes
Marius is an XDR-TB survivor from South Africa who participated in the Nix-TB clinical trial.
Read more about his story here:
Tsholofelo was diagnosed with XDR-TB before participating in Nix-TB.
This is her story:
Innocent is an XDR-TB survivor from Johannesburg, South Africa.
Find out more about his story here:
Join the conversation
We’ve created a social media toolkit with photos and videos to highlight this new TB treatment, as well as quotes from key leaders who were instrumental in the development of this drug. Please make use of this content as you see fit.
Please note that this content is under embargo until the FDA decision is announced, expected on August 14, 2019 (date subject to change).
Additional Resources
About TB Alliance
TB Alliance is a not-for-profit organization dedicated to finding faster-acting and affordable drug regimens to fight TB. Through innovative science and with partners around the globe, we aim to ensure equitable access to faster, better TB cures that will advance global health and prosperity. TB Alliance operates with support from Australia’s Department of Foreign Affairs and Trade, Bill & Melinda Gates Foundation, Cystic Fibrosis Foundation, European & Developing Countries Clinical Trials Partnership, Germany’s Federal Ministry of Education and Research through KfW, Global Health Innovative Technology Fund, Indonesia Health Fund, Irish Aid, Medical Research Council (United Kingdom), National Institute of Allergy and Infectious Disease, Netherlands Ministry of Foreign Affairs, United Kingdom Department for International Development, and the United States Agency for International Development.